Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 4
Results: 40
Improved home management of oral pediatric anticancer drugs as a result of an intervention comprising practical training, written instructions and movie clips: A pilot study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 818, doi. 10.1177/10781552221080445
- By:
- Publication type:
- Article
Health-related quality of life of women with breast cancer being treated with hormone therapy: A scoping review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 944, doi. 10.1177/10781552231168071
- By:
- Publication type:
- Article
Response to letter to the editor: Use, response and outcomes of second line chemotherapy in patients with advanced biliary tract cancers.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Outpatient administration of paclitaxel, ifosfamide, and cisplatin (TIP) for germ cell tumor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 912, doi. 10.1177/10781552231165243
- By:
- Publication type:
- Article
Response letter to "Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 934, doi. 10.1177/10781552231162545
- By:
- Publication type:
- Article
Cost-effectiveness of pembrolizumab in first-line for microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancerF.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 958, doi. 10.1177/10781552231159844
- By:
- Publication type:
- Article
Optimal regimen of levetiracetam for prevention of busulfan-induced seizure in patients undergoing hematopoietic stem cell transplantation: A review of available evidence.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 927, doi. 10.1177/10781552231159056
- By:
- Publication type:
- Article
Oncology stewardship: Role of the pharmacists for contribution in low and middle-income countries.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 956, doi. 10.1177/10781552231154465
- By:
- Publication type:
- Article
Changing therapeutic landscape in advanced Kaposi sarcoma: Current state and future directions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 917, doi. 10.1177/10781552221148417
- By:
- Publication type:
- Article
Pneumonitis associated with bortezomib in a patient with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 1021, doi. 10.1177/10781552221143789
- By:
- Publication type:
- Article
Possible heart failure caused by osimertinib in a lung cancer patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 1015, doi. 10.1177/10781552221143787
- By:
- Publication type:
- Article
Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 1011, doi. 10.1177/10781552221142870
- By:
- Publication type:
- Article
Siltuximab as a primary treatment for cytokine release syndrome in a patient receiving a bispecific antibody in a clinical trial setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 1006, doi. 10.1177/10781552221140320
- By:
- Publication type:
- Article
Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 1002, doi. 10.1177/10781552221139773
- By:
- Publication type:
- Article
Mercaptopurine induced myelosuppression in a child with a NUDT15 rs116855232 homozygous variant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 999, doi. 10.1177/10781552221137709
- By:
- Publication type:
- Article
Non-Hodgkin's lymphoma developed during imatinib mesylate treatment of chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 996, doi. 10.1177/10781552221137700
- By:
- Publication type:
- Article
Safe administration of temozolomide in end-stage renal disease patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 992, doi. 10.1177/10781552221131908
- By:
- Publication type:
- Article
Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete response.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 986, doi. 10.1177/10781552221127699
- By:
- Publication type:
- Article
Radiation recall myositis with pazopanib in a patient with soft tissue sarcoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 980, doi. 10.1177/10781552221125869
- By:
- Publication type:
- Article
Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 975, doi. 10.1177/10781552221125763
- By:
- Publication type:
- Article
Lenalidomide induced pneumonitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 971, doi. 10.1177/10781552221124533
- By:
- Publication type:
- Article
Novel approach of desensitization in allergic reaction to Olaparib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 967, doi. 10.1177/10781552221124041
- By:
- Publication type:
- Article
Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 962, doi. 10.1177/10781552221122057
- By:
- Publication type:
- Article
Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 905, doi. 10.1177/10781552221090965
- By:
- Publication type:
- Article
A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 899, doi. 10.1177/10781552221089243
- By:
- Publication type:
- Article
The efficacy and cost-impact of rasburicase 3 mg versus 6 mg for the management of tumor lysis syndrome: A multicenter analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 893, doi. 10.1177/10781552221087978
- By:
- Publication type:
- Article
Late side effects of cancer treatment in childhood cancer survivors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 885, doi. 10.1177/10781552221087611
- By:
- Publication type:
- Article
Evaluation of antibiotic appropriateness at an outpatient oncology centre.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 874, doi. 10.1177/10781552221087604
- By:
- Publication type:
- Article
Evaluation of voriconazole related adverse events in pediatric patients with hematological malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 861, doi. 10.1177/10781552221086887
- By:
- Publication type:
- Article
EGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 854, doi. 10.1177/10781552221085253
- By:
- Publication type:
- Article
Community pharmacists preparedness and barriers for cancer health promotion in North Cyprus.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 846, doi. 10.1177/10781552221084920
- By:
- Publication type:
- Article
Evaluation of the efficacy of ursodiol for prevention of hepatotoxicity in patients receiving gemtuzumab ozogamicin and inotuzumab ozogamicin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 840, doi. 10.1177/10781552221084000
- By:
- Publication type:
- Article
Perceptions of PGY-2 Oncology Programs on Financial Toxicity Education and Preparedness.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 833, doi. 10.1177/10781552221082214
- By:
- Publication type:
- Article
Oral cancer awareness and education within the pharmacy profession.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 826, doi. 10.1177/10781552221081387
- By:
- Publication type:
- Article
Atopy, allergen sensitization and development of hypersensitivity reactions to paclitaxel.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 810, doi. 10.1177/10781552221080415
- By:
- Publication type:
- Article
Evaluation of a Pharmacist-Developed, Nurse-Driven Protocol for Management of Parenteral Anticancer Therapy Infusion Reactions in an Ambulatory Infusion Center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 802, doi. 10.1177/10781552221079855
- By:
- Publication type:
- Article
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 794, doi. 10.1177/10781552221079568
- By:
- Publication type:
- Article
Pembrolizumab for advanced non-small cell lung cancer (NSCLC): Impact of autoimmune comorbidity and outcomes following treatment completion.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 785, doi. 10.1177/10781552221079356
- By:
- Publication type:
- Article
Toxicity profile, adverse drug reactions and drug-drug interactions among geriatric cancer patients under metronomic chemotherapy in a South Indian tertiary care hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 778, doi. 10.1177/10781552221078934
- By:
- Publication type:
- Article